Skip to content
10-Q

Quarterly Report

NAVIDEA BIOPHARMACEUTICALS, INC.

0001437749-23-032052

← back to feed
Filed
Nov 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 10, 2023 100.08M sh
Capex Q3 2023 · Sep 30, 2023 $15.07K
Capex Q3 2023 · Sep 30, 2022 $14.43K
Capex Q3 2023 · Sep 30, 2022 $63.09K
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$7.28M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$6.55M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $3.86M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $2M
Stockholders Equity Q3 2023 · Sep 30, 2023 −$3.27M
Stockholders Equity Q3 2023 · Dec 31, 2022 −$8.44M
Current Liabilities Q3 2023 · Sep 30, 2023 $7.98M
Current Liabilities Q3 2023 · Dec 31, 2022 $9.94M
Total Liabilities Q3 2023 · Sep 30, 2023 $8.68M
Total Liabilities Q3 2023 · Dec 31, 2022 $12.51M
Current Assets Q3 2023 · Sep 30, 2023 $4.5M
Current Assets Q3 2023 · Dec 31, 2022 $3.2M
Total Assets Q3 2023 · Sep 30, 2023 $5.7M
Total Assets Q3 2023 · Dec 31, 2022 $4.37M
Eps Basic Q3 2023 · Sep 30, 2023 −$0.02
Eps Basic Q3 2023 · Sep 30, 2023 $0.03
Eps Basic Q3 2023 · Sep 30, 2022 −$0.25
Eps Basic Q3 2023 · Sep 30, 2022 −$0.45
Sga Expense Q3 2023 · Sep 30, 2023 $1.3M
Sga Expense Q3 2023 · Sep 30, 2023 $3.78M
Sga Expense Q3 2023 · Sep 30, 2022 $3.64M
Sga Expense Q3 2023 · Sep 30, 2022 $6.7M
Rd Expense Q3 2023 · Sep 30, 2023 $829.61K
Rd Expense Q3 2023 · Sep 30, 2023 $3.2M
Rd Expense Q3 2023 · Sep 30, 2022 $1.19M
Rd Expense Q3 2023 · Sep 30, 2022 $4.08M
Operating Income Q3 2023 · Sep 30, 2023 −$2.13M
Operating Income Q3 2023 · Sep 30, 2023 −$6.98M
Operating Income Q3 2023 · Sep 30, 2022 −$4.95M
Operating Income Q3 2023 · Sep 30, 2022 −$10.85M
Gross Profit Q3 2023 · Sep 30, 2023 $0
Gross Profit Q3 2023 · Sep 30, 2023 $0
Gross Profit Q3 2023 · Sep 30, 2022 −$126.92K
Gross Profit Q3 2023 · Sep 30, 2022 −$69.87K
Revenue Q3 2023 · Sep 30, 2023 $0
Revenue Q3 2023 · Sep 30, 2023 $0
Revenue Q3 2023 · Sep 30, 2022 $7.52K
Revenue Q3 2023 · Sep 30, 2022 $65.04K
Cost Of Revenue Q3 2023 · Sep 30, 2022 $1.43K
Cost Of Revenue Q3 2023 · Sep 30, 2022 $1.91K